Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valter Torri

Showing results (91-100 of 228) with videos related to

Pageof 23
Sort By:
Neurobiology of Disease|February 23, 2020
Diagnostic and prognostic values of PBMC proteins in amyotrophic lateral sclerosisSilvia Luotti, Laura Pasetto, Luca Porcu, et al.
BMJ Open|August 1, 2022
Prophylactic surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC CO2) versus standard surgery in colorectal carcinoma at high risk of peritoneal carcinomatosis: short-term and long-term outcomes from the CHECK study - protocol for a randomised, multicentre, phase 3 trialFabio Pacelli, Chiara Gerardi, Eliana Rulli, et al.
Journal of the Neurological Sciences|April 12, 2019
Prognostic nutritional index as a prognostic marker in glioblastoma: Data from a cohort of 282 Italian patientsAndrea Rigamonti, Francesca Imbesi, Antonio Silvani, et al.
Advances in Therapy|December 20, 2018
Pan-European Expert Meeting on the Use of Metronomic Chemotherapy in Advanced Breast Cancer Patients: The PENELOPE ProjectMarina E Cazzaniga, Elisabetta Munzone, Guido Bocci, et al.
Journal of Glaucoma|September 29, 2017
The Glaucoma Italian Pediatric Study (GIPSy): 1-Year ResultsLuciano Quaranta, Elena Biagioli, Ivano Riva, et al.
ESMO Open|November 26, 2020
Implementing clinical practice guidelines: time to assess itCristiana Sessa, Nicoletta Colombo, Carien L Creutzberg, et al.
Journal of the National Cancer Institute|April 10, 2025
Neoadjuvant versus perioperative chemo-immunotherapy according to pathological response in resectable NSCLC: a reconstructed individual patient data meta-analysisAntonio Nuccio, Fabio Salomone, Alberto Servetto, et al.
Therapeutic Advances in Medical Oncology|September 18, 2023
What is the ideal endpoint in early-stage immunotherapy neoadjuvant trials in lung cancer?Robert B Cameron, Jacobi B Hines, Valter Torri, et al.
American Journal of Clinical Oncology|February 11, 2003
Phase II study of Taxol combined With ifosfamide and carboplatin in the treatment of stage IIIb-IV non-small-cell lung cancerAlberto Zaniboni, Andrea Ardizzoni, Filippo De Marinis, et al.
ESMO Open|December 18, 2018
Chemotherapy versus erlotinib as second-line treatment in patients with advanced non-small cell lung cancer and wild-type epidermal growth factor receptor: an individual patient data (IPD) analysisMarina Chiara Garassino, Tomoya Kawaguchi, Vanesa Gregorc, et al.
Pageof 23

Showing results (91-100 of 228) with videos related to

Sort By:
Pageof 23
Neurobiology of Disease|February 23, 2020
Diagnostic and prognostic values of PBMC proteins in amyotrophic lateral sclerosisSilvia Luotti, Laura Pasetto, Luca Porcu, et al.
BMJ Open|August 1, 2022
Prophylactic surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC CO2) versus standard surgery in colorectal carcinoma at high risk of peritoneal carcinomatosis: short-term and long-term outcomes from the CHECK study - protocol for a randomised, multicentre, phase 3 trialFabio Pacelli, Chiara Gerardi, Eliana Rulli, et al.
Journal of the Neurological Sciences|April 12, 2019
Prognostic nutritional index as a prognostic marker in glioblastoma: Data from a cohort of 282 Italian patientsAndrea Rigamonti, Francesca Imbesi, Antonio Silvani, et al.
Advances in Therapy|December 20, 2018
Pan-European Expert Meeting on the Use of Metronomic Chemotherapy in Advanced Breast Cancer Patients: The PENELOPE ProjectMarina E Cazzaniga, Elisabetta Munzone, Guido Bocci, et al.
Journal of Glaucoma|September 29, 2017
The Glaucoma Italian Pediatric Study (GIPSy): 1-Year ResultsLuciano Quaranta, Elena Biagioli, Ivano Riva, et al.
ESMO Open|November 26, 2020
Implementing clinical practice guidelines: time to assess itCristiana Sessa, Nicoletta Colombo, Carien L Creutzberg, et al.
Journal of the National Cancer Institute|April 10, 2025
Neoadjuvant versus perioperative chemo-immunotherapy according to pathological response in resectable NSCLC: a reconstructed individual patient data meta-analysisAntonio Nuccio, Fabio Salomone, Alberto Servetto, et al.
Therapeutic Advances in Medical Oncology|September 18, 2023
What is the ideal endpoint in early-stage immunotherapy neoadjuvant trials in lung cancer?Robert B Cameron, Jacobi B Hines, Valter Torri, et al.
American Journal of Clinical Oncology|February 11, 2003
Phase II study of Taxol combined With ifosfamide and carboplatin in the treatment of stage IIIb-IV non-small-cell lung cancerAlberto Zaniboni, Andrea Ardizzoni, Filippo De Marinis, et al.
ESMO Open|December 18, 2018
Chemotherapy versus erlotinib as second-line treatment in patients with advanced non-small cell lung cancer and wild-type epidermal growth factor receptor: an individual patient data (IPD) analysisMarina Chiara Garassino, Tomoya Kawaguchi, Vanesa Gregorc, et al.
Pageof 23